News Daily News Community Health Workers Boost BP Control in South Asian Immigrants Todd Neale February 24, 2023
News Daily News Acute Cardiac Events More Common in COVID-19 Patients With Heart Histories Caitlin E. Cox February 10, 2023
News Daily News BP Reduction With Renal Denervation Still Evident a Decade On Michael O'Riordan January 31, 2023
News Daily News More Frequent, Longer Movement Breaks Can Attenuate Harms of Sitting Yael L. Maxwell January 13, 2023
News Daily News Hypertension and Heavy Coffee Consumption a Bad Combo, Study Finds L.A. McKeown December 29, 2022
News Daily News Effect of Intensive BP-Lowering on Cardiac Biomarkers Varies: SPRINT Analysis Todd Neale December 23, 2022
News Daily News ACC’s Valve Staging Tool Reveals Silent Disease is Common in the Elderly L.A. McKeown December 22, 2022
News Daily News Reduction in BP Drives Treatment Preference for Hypertensive Patients Michael O'Riordan December 20, 2022
News Daily News CVD Claimed 20 Million Lives in 2021, but Disease Burden Varies Globally Michael O'Riordan December 14, 2022
News Daily News Large Review Plumbs Possibilities, Pointlessness of Antioxidant Supplements Michael O'Riordan December 07, 2022
News Daily News Novel Aldosterone Synthase Inhibitor Drops BP: Top-line Phase II Results Todd Neale November 16, 2022
News Conference News AHA 2022 Sizeable Minority of Pregnant Women Have CVD, US Data Show Caitlin E. Cox November 11, 2022
News Conference News AHA 2022 Endothelin Receptor Antagonist Effective in Resistant Hypertension: PRECISION Michael O'Riordan November 09, 2022
News Conference News AHA 2022 China Rural Intervention Still Reaping BP Control Wins at 3 Years L.A. McKeown November 09, 2022
News Conference News AHA 2022 SPYRAL HTN-ON MED Trial of Renal Denervation Misses Primary Endpoint Todd Neale November 09, 2022
News Conference News AHA 2022 Four Drugs, One Pill: QUARTET USA Supports New Strategy for BP-Lowering Caitlin E. Cox November 08, 2022
News Conference News AHA 2022 Big Drops in Blood Pressure With Baxdrostat: BrigHTN Phase II Study Michael O'Riordan November 07, 2022
News Conference News AHA 2022 In High BP, Chlorthalidone and Hydrochlorothiazide Have Similar Impact on MACE Todd Neale November 05, 2022
News Daily News SPRINT Turns Sluggish: Mortality Benefits Vanish Once Normal BP Care Resumes Michael O'Riordan October 18, 2022
News Conference News TCT 2022 SYMPLICITY HTN-3’s Late Surprise: Sustained BP Drop at 3 Years Despite Earlier Miss Michael O'Riordan September 19, 2022